معرفی
Silvia Giordano is a Professor at the Department of Oncology, University of Turin. Her research focuses on oncology, molecular medicine, and cancer biology, with particular emphasis on gastric cancer, targeted therapies, and drug development. She contributes to courses like Basis of Human Morphology and Molecular bases of targeted therapies. Giordano leads studies on tumor cell signaling, resistance mechanisms, and translational models, including patient-derived xenograft (PDX) collections. She collaborates with institutions like the IRCCS Candiolo Cancer Institute and serves on academic bodies such as the Department Council. Her work bridges basic research and clinical applications, addressing challenges in cancer treatment and drug resistance. She has published extensively on topics like MET receptor biology, hepatocellular carcinoma models, and synergistic chemotherapy combinations.
